AVANIR PHARMACEUTICALS, INC. - FORM 10-Q - EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER - May 9, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AVANIR PHARMACEUTICALS, INC.Financial_Report.xls
10-Q - FORM 10-Q - AVANIR PHARMACEUTICALS, INC.d345387d10q.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER REQUIRED UNDER RULE 13A-14(A) - AVANIR PHARMACEUTICALS, INC.d345387dex311.htm
EX-10.1 - FORM OF INDEMNIFICATION AGREEMENT WITH CERTAIN DIRECTORS AND EXECUTIVE OFFICERS - AVANIR PHARMACEUTICALS, INC.d345387dex101.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER REQUIRED UNDER RULE 13A-14(A) - AVANIR PHARMACEUTICALS, INC.d345387dex312.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)

In connection with the accompanying Quarterly Report of Avanir Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the fiscal quarter ended March 31, 2012 (the “Report”), I, Keith A. Katkin, as Chief Executive Officer of the Company, and Christine G. Ocampo, as Vice President, Finance of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: May 9, 2012      

/s/ Keith A. Katkin

      Keith A. Katkin
     

President and Chief Executive Officer

[Principal Executive Officer]

Dated: May 9, 2012      

/s/ Christine G. Ocampo

     

Christine G. Ocampo

Vice President, Finance

      [Principal Financial Officer and Principal Accounting Officer]

AVANIR PHARMACEUTICALS, INC. Reports